Your browser doesn't support javascript.
loading
"I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya.
Kimani, Makobu; van der Elst, Elise M; Chirro, Oscar; Wahome, Elizabeth; Ibrahim, Fauz; Mukuria, Nana; de Wit, Tobias F Rinke; Graham, Susan M; Operario, Don; Sanders, Eduard J.
Afiliação
  • Kimani M; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya.
  • van der Elst EM; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya.
  • Chirro O; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya.
  • Wahome E; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya.
  • Ibrahim F; Department of Health, Kilifi County, Kilifi, Kenya.
  • Mukuria N; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya.
  • de Wit TFR; Department of Global Health, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands.
  • Graham SM; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
  • Operario D; Department of Public Health, Brown University, Providence, Rhode Island, United States of America.
  • Sanders EJ; KEMRI-Wellcome Trust Research Program, Kilifi, Kenya.
PLoS One ; 16(1): e0244226, 2021.
Article em En | MEDLINE | ID: mdl-33465090
ABSTRACT

BACKGROUND:

Transgender women (TGW) and men who have sex with men (MSM) in sub-Saharan Africa have high HIV acquisition risks and can benefit from daily pre-exposure prophylaxis (PrEP). We assessed PrEP adherence by measuring tenofovir-diphosphate (TFV-DP) levels and explore motives for PrEP persistence in TGW and MSM.

METHODS:

Participants were enrolled in a one-year PrEP programme and made quarterly visits irrespective of whether they were still using PrEP. At their month 6 visit, participants provided a dried blood spot to test for TFV-DP levels; protective levels were defined as those compatible with ≥4 pills per week (700-1249 fmol/punch). Before TFV-DP levels were available, a sub-set of these participants were invited for an in-depth interview (IDI). Semi-structured IDI topic guides were used to explore motives to uptake, adhere to, and discontinue PrEP. IDI data were analyzed thematically.

RESULTS:

Fifty-three participants (42 MSM and 11 TGW) were enrolled. At month 6, 11 (20.7%) participants (8 MSM and 3 TGW) were lost to follow up or stopped taking PrEP. Any TFV-DP was detected in 62.5% (5/8) of TGW vs. 14.7% of MSM (5/34, p = 0.01). Protective levels were detected in 37.5% of TGW (3/8), but not in any MSM. Nineteen IDI were conducted with 7 TGW and 9 MSM on PrEP, and 1 TGW and 2 MSM off PrEP. Unplanned or frequent risky sexual risk behaviour were the main motives for PrEP uptake. Among participants on PrEP, TGW had a more complete understanding of the benefits of PrEP. Inconsistent PrEP use was attributed to situational factors. Motives to discontinue PrEP included negative reactions from partners and stigmatizing healthcare services.

CONCLUSION:

While MSM evinced greater adherence challenges in this PrEP programme, almost 40% of TGW were protected by PrEP. Given high HIV incidences in TGW these findings hold promise for TGW PrEP programming in the region.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Homossexualidade Masculina / Fármacos Anti-HIV / Pessoas Transgênero / Profilaxia Pré-Exposição Tipo de estudo: Etiology_studies / Qualitative_research Limite: Adolescent / Adult / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Homossexualidade Masculina / Fármacos Anti-HIV / Pessoas Transgênero / Profilaxia Pré-Exposição Tipo de estudo: Etiology_studies / Qualitative_research Limite: Adolescent / Adult / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article